| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $16.73 | $16.59 | $15.97 | $14.00 | $10.00 | $8.31 | $2.72 | $1.39 |
| EPS (Diluted) | $16.62 | $16.44 | $15.81 | $13.87 | $9.92 | $8.27 | $2.70 | $1.35 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $35.4B | $31.3B | $29.5B | $27.3B | $25.1B | $24.4B | $21.7B | $15.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | $0.9B | $0.9B | $0.9B | $1.0B | $0.6B | $1.2B |
| Total Liabilities | $33.7B | $29.8B | $28.1B | $26.1B | $23.9B | $23.4B | $20.9B | $15.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.7B | $1.5B | $1.4B | — | — | — | — | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.6B | $0.4B | $0.8B | $0.4B | $-0.1B | $-0.0B | $0.2B |
| Investing Cash Flow | $-3.8B | $-1.7B | $-2.0B | $-3.0B | $-1.1B | $-1.7B | $-2.4B | $-1.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $3.6B | $1.2B | $1.6B | $2.2B | $0.5B | $2.3B | $2.6B | $0.9B |